Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 72.635 USD 2.88%
Market Cap: 12.5B USD
Have any thoughts about
Insmed Inc?
Write Note

Insmed Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insmed Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Insmed Inc
NASDAQ:INSM
Cash from Financing Activities
$909m
CAGR 3-Years
13%
CAGR 5-Years
27%
CAGR 10-Years
30%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Insmed Inc's Cash from Financing Activities?
Cash from Financing Activities
909m USD

Based on the financial report for Jun 30, 2024, Insmed Inc's Cash from Financing Activities amounts to 909m USD.

What is Insmed Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
30%

Over the last year, the Cash from Financing Activities growth was 10%. The average annual Cash from Financing Activities growth rates for Insmed Inc have been 13% over the past three years , 27% over the past five years , and 30% over the past ten years .

Back to Top